www.cancerindetail.com

Late Stage Cancer Treatment Trends, Multiple Myeloma Vaccine, Predictors of Cancer Survival Among...

2 hrs ago | news.yahoo.com

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, HPV-positive head and neck cancer, a promising multiple myeloma vaccine, and predictive... Read more...
All similar articles: 77 >>

Sinai cancer patient Mount survival treatment CyNx chemoradiotherapy HPV-positive vaccine Oncology Galsky Myeloma predictive tumor Hematology PARADIGM

Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer

3 hrs ago | eurekalert.org

For some patients with muscle-invasive bladder cancer, treatment may begin before they undergo cystectomy, or surgical removal of the bladder. They may be advised by oncologists to receive chemotherapy before surgery. A large... Read more...

bladder MVAC muscle-invasive AMVAC cancer chemotherapy patient Chase Plimack Fox accelerated surgery neoadjuvant cystectomy regimen

MD Anderson in Sugar Land Adds Specialist in Prostate, Genitourinary Cancers

19 hrs ago | mdanderson.org

John Papadopoulos, M.D., has joined The University of Texas MD Anderson Cancer Center's Regional Care Center in Sugar Land, providing the community a new level of expertise in cancers of the prostate, kidneys and bladder.... Read more...
All similar articles: 56 >>

Papadopoulos prostate cancer MD Anderson Sugar patient Land specialist treatment

Robin Quivers of the Howard Stern Show May Have Cancer

May 14, 2012 | webpronews.com

Robin Quivers, the co-host of the Howard Stern Show, announced on air this morning that she may have cancer. She has an appointment today with a specialist to determine if a growth she has pressing on her bladder is cancerous … Read more...

Rich Ord quiver Stern Robin cancer Howard bladder TSA pressing

image

Symptoms and treatment for bladder cancer

May 10, 2012 | foxnews.com

Bladder cancer begins in the bladder, a central organ in the urinary system. The National Cancer Institute reports that 14,880 people will die from bladder cancer and 73,510 new cases of the disease will be diagnosed this year.... Read more...

bladder cancer urothelium symptom tumor urine treatment

Firefighter hopes death will boost awareness of job’s hazards

May 9, 2012 | metronews.ca

Peter Czulinski never thought cancer would deliver the fatal blow. Like all firefighters, he thought he might die — if he thought about death at all — in a roaring blaze, working side by side with his colleagues, fighting to …... Read more...

Czulinski cancer firefighter WSIB Ontario occupational hazard

Today's Bio-Pharma Catalyst Trades And ASCO Movers

May 8, 2012 | seekingalpha.com

By Scott Matusow : As I've referred to in previous articles, this time of the year the spotlight turns to the June ASCO meetings in Chicago, IL. ASCO stands for the American Society of Clinical Oncology and is the premier event... Read more...

Scott Matusow ASCO Sunesis Bio-Pharma Vosaroxin catalyst Ariad Ponatinib bladder pps trade BCR-ABL SecreFlo

Prevacid solutab coupon rebate

May 4, 2012 | elpais.com

Accutane west palm beach Alcohol micardis tablets Allegra dosage information Poker sites legal in usa Hydrocodone apap 5mg 500mg side effects Allegra allergy review One for the money movie review Actos jurisdicciуn voluntaria... Read more...

Accutane Amoxicillin Ambien Allegra Alprazolam Abilify Advair Actos dosage mg Acyclovir Amitriptyline money effect Adalat

OncoGenex Pharmaceuticals, Inc. Reports Financial Results and Reviews Clinical Development...

May 3, 2012 | finanznachrichten.de

Conference call to be held on Thursday, May 3, 2012 at 4:30 p.m. Eastern Time BOTHELL, WA, and VANCOUVER, May 3, 2012 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced first quarter 2012 financial... Read more...

OGX-427 OncoGenex custirsen clinical CRPC patient Phase result bladder cancer development

Bioniche Life Sciences Inc. Commercializing Two Products for Canine Cancer

May 3, 2012 | pr-usa.net

Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it is commercializing two canine cancer products, one of which is expected to be... Read more...

Bioniche cancer canine dog product mammary Urocidin Immunocidin chemotherapy Inc. TM Sciences human

Chemoradiation May Help Some Patients with Bladder Cancer Avoid Radical Surgery

May 2, 2012 | cancer.gov

Researchers in the United Kingdom have found that adding chemotherapy to radiation therapy as a treatment for bladder cancer may reduce the risk of a recurrence more than radiation alone, without causing a substantial increase... Read more...

bladder chemoradiation cancer muscle-invasive patient surgery chemotherapy radiation therapy Dr.

image

Bladder Cancer: New Data from Qingdao Agricultural University Illuminate Research in Bladder Cancer

Apr 24, 2012 | newsrx.com

New research, "Alteration in methylation pattern of oncogene Akt1 promoter region in bladder cancer," is the subject of a report. "The oncogene Akt1 plays a pivotal role in regulating growth factor-associated cell survival. The... Read more...

bladder Akt1 cancer Qingdao methylation oncogene Akt X.F.

Health Canada Says Actos Raises Bladder Cancer Risks

Apr 23, 2012 | newsinferno.com

Health Canada just announced that Type 2 diabetes drug, Actos, raises risks for bladder cancer. Actos maker, Takeda Canada, Inc., was part of the joint announcement. The statement followed a safety assessment announced last... Read more...

Actos bladder cancer Takeda Ge Canada risk

LawyersAndSettlements.com Reports 250% Increase In Actos Complaints

Apr 23, 2012 | webwire.com

SANTA CRUZ, Calif., April 23,, 2012 – On March 27, 2012 the American Diabetes Association Alert Day® called on Americans to assess their risk for developing type 2 diabetes. According to the Centers for Disease Control and... Read more...

Actos Avandia LawyersandSettlements.com diabetes 250 Legal complaint bladder

Spectrum Could Sink In Wake Of Trial Failures

Apr 22, 2012 | seekingalpha.com

April 22, 2012 by: Investment Underground | about: by Erica Thinesen Over the past few weeks, Spectrum has received a lot of attention, mostly due to the failure of two clinical trials for its drug aqaziquone, used in the... Read more...

Investment Underground Spectrum drug cancer trial SmallCap clinical FDA failure aqaziquone Fotolyn Allos 600 investor blood Mylotarg Sanofi approval Index Zevalin treatment

Cancer Prevention and Green Tea Intake

Apr 21, 2012 | goarticles.com

in Health / Cancer (submitted 2012-04-21) Drinkers of green tea are said to be not as susceptible to cancer as are non-drinkers. Clinical studies have borne this out. It has been popular with the Chinese for many years - they... Read more...

cancer tea esophageal green bladder polyphenol study effective herbal

Diabetes drug Actos may pose bladder cancer risk

Apr 20, 2012 | cbc.ca

Diabetes, a growing global health problem Actos safey information, Health Canada (Note:CBC does not endorse and is not responsible for the content of external links.) Taking the diabetes drug Actos may increase one's risk of... Read more...

Actos bladder drug diabetes cancer risk Juurlink Avandia Health Canada Takeda

image

Adding Chemo to Radiation Cuts Bladder Cancer Recurrence (CME/CE)

Apr 18, 2012 | medpagetoday.com

By Kristina Fiore, Staff Writer, MedPage Today Published: April 18, 2012 Reviewed by Robert Jasmer, MD ; Associate Clinical Professor of Medicine, University of California, San Francisco. Giving combination chemotherapy at the... Read more...

bladder chemoradiotherapy radiotherapy cancer muscle-invasive recurrence Zietman chemotherapy radiation locoregional cystectomy patient researcher

Wales News: Combined treatment can cut bladder cancer relapse rates

Apr 18, 2012 | icnetwork.co.uk

BLADDER cancer patients who receive low doses of chemotherapy alongside radiotherapy are significantly less likely to relapse with the most lethal form of the disease compared to those treated with just radiotherapy, a major... Read more...
All similar articles: 68 >>

bladder radiotherapy cancer relapse patient chemoradiotherapy treatment chemotherapy invasive Wales disease surgery

image

Chemo + Radiation Best for Bladder Cancer, Study Finds

Apr 18, 2012 | msn.com

Adding fluorouracil, mitomycin C led to significantly better survival rates By Maureen SalamonHealthDay Reporter WEDNESDAY, April 18 (HealthDay News) -- The addition of two well-tolerated chemotherapy drugs to radiation therapy... Read more...

bladder radiation cancer chemotherapy study survival oncology mitomycin patient Vira fluorouracil urologic

image

What Are Gallstones? What Causes Gallstones?

Apr 18, 2012 | goarticles.com

A gallbladder, usually categorised as the Important body part of the human body, is really a small to medium sized part placed just under the right part of the liver organ. The gallbladder therefore, does ... Read more...

gallbladder gall surgical looseness bladder bowel organ cause body procedure bile operation

Celek Pharmaceuticals to Present Recent Progress on its Anticancer Drug Candidate, CEL-031, at...

Apr 18, 2012 | fortmilltimes.com

Celek Pharmaceuticals announced that it will present an update on its anticancer drug development programs today at the National Cancer Institute (NCI)’s 2012 Investor Forum in Santa Clara, CA. The NCI selected Celek as one of... Read more...

CEL-031 Celek NMIBC AML NCI bladder cancer

Cubist Announces Positive Results from ENTEREG® Phase 4 Study in Patients Undergoing Radical...

Apr 17, 2012 | finanznachrichten.de

Company Expects to File sNDA by End of 2012 Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that a Phase 4 study of ENTEREG®(alvimopan) in patients undergoing radical cystectomy met its primary endpoint of time to... Read more...

ENTEREG Cubist cystectomy patient radical study undergoing treatment-emergent

Spectrum bladder cancer drug unsuccessful - new c&m news published

Apr 16, 2012 | pr-inside.com

Spectrum Pharmaceuticals Inc has said its trial drug used to treat bladder cancer was unsuccessful in its attempts to notably reduce the recurrence of tumours in late-stage trials, decreasing its share price to 16 percent in... Read more...

c&m bladder unsuccessful drug cancer spectrum late-stage apaziquone Healthcare-and-Medical

AA in herbal medicine linked to bladder cancer

Apr 11, 2012 | etaiwannews.com

Study shows the widespread use of AA-containing plants in Chinese herbal medicine is a significant factor in the growth of urothelial cancers in Taiwan over the past quarter century A study published online Monday by the... Read more...

urothelial AA herbal cancer bladder medicine aristolochic Taiwan AA-containing weight-loss Asarum Aristolochia

Reconstructive surgery offers new lease of life

Apr 7, 2012 | zawya.com

Saturday, Apr 07, 2012 Gulf NewsAbu Dhabi For the first time in the emirate, a surgery was successfully completed to reconstruct a bladder using the patient’s intestines. The procedure was carried out at Al Mafraq Hospital on a... Read more...

bladder Mekresh patient surgery Mafraq Al cancer uro cystectomy urostomy ureter prostate life intestine cancerous anastomosed reconstruct Sherif?Staff

Sentenced to death for being old: The NHS denies life-saving treatment to the elderly, as one...

Apr 7, 2012 | dailymail.co.uk

When Kenneth Warden was diagnosed with terminal bladder cancer, his hospital consultant sent him home to die, ruling that at 78 he was too old to treat. Even the palliative surgery or chemotherapy that could have eased his... Read more...

John Naish treatment NHS Michele life-saving consultant elderly father bladder tumor Kenneth old chemotherapy cancer radiotherapy symptom Macmillan cystectomy deny surgery Devane age Dad patient

image

Spectrum Pharmaceuticals Announces Results of Apaziquone Phase 3 Clinical Trials

Apr 6, 2012 | finanzen.net

Spectrum Pharmaceuticals zu myNews hinzufügen Was ist das? Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology... Read more...

Apaziquone Spectrum clinical drug Pharmaceuticals trial NMIBC FUSILEV p-value recurrence bladder Company statement placebo endpoint

Spectrum says bladder cancer drug fails, buys Allos

Apr 5, 2012 | reuters.com

Spectrum Pharmaceuticals Inc (SPPI.O) said its experimental drug to treat a common form of bladder cancer failed to significantly reduce the recurrence of tumors in late-stage trials, sending its shares down 14 percent.... Read more...
All similar articles: 67 >>

Anand Basu Allos bladder spectrum drug Folotyn NMIBC cancer Zavoico Zevalin Shrotriya apaziquone late-stage fail

Sandra Steingraber: Cancer in the Ransom Note

Apr 5, 2012 | huffingtonpost.com

Why should cancer patients in the United States and Canada -- and those who love or diagnose them -- care about a report about looming water shortages in distant countries such as South Africa and Argentina? Read more...

Sandra Steingraber fracking cancer water Steingraber carcinogen Sandra ransom benzene Crisis fracked chemical

image